Skip to content

Dr. Peyman Taeidi

Cellular Biologist San Diego, CA.

  • Dr. Peyman Taeidi
  • Articles
  • News
A father had a heart attack at 56. His son’s technology could’ve predicted it
  • More Science

A father had a heart attack at 56. His son’s technology could’ve predicted it

  • Peyman Taeidi
  • March 27, 2023

He used the tools to study how the mechanical forces of heart contractions, blood flow

The Twin Attack on Liberty from Technocracy and Transhumanism
  • More Science

The Twin Attack on Liberty from Technocracy and Transhumanism

  • Peyman Taeidi
  • March 27, 2023

The Twin Attack on Liberty from Technocracy and Transhumanism – American Thinker March 27, 2023

  • More Science

EVŌQ Nano Presents Breakthrough Nanoparticle Research at ACS Spring 2023 Conference

  • Peyman Taeidi
  • March 27, 2023

Nanoparticle EVQ-218 measures up to NIST Standards SALT LAKE CITY and INDIANAPOLIS, March 27, 2023

  • More Science

UPSC Key- March 27, 2023: Know about One country-two system, Tactical nuclear weapons, Tornado and Hundi

  • Peyman Taeidi
  • March 27, 2023

THE WORLD PROTEST IN HONG KONG FOR FIRST TIME IN YEARS Syllabus: Preliminary Examination: Current events

the UAE promotes the Fourth industrial revolution
  • More Science

the UAE promotes the Fourth industrial revolution

  • Peyman Taeidi
  • March 27, 2023

the UAE promotes the Fourth industrial revolution – Nanotechnology News Today – EIN Presswire Trusted

  • More Science

Midatech Pharma PLC Announces R&D Programme Focused on Leptomeningeal Disease

  • Peyman Taeidi
  • March 27, 2023

ABINGDON, OXFORDSHIRE / ACCESSWIRE / March 27, 2023 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), a drug

  • More Science

Midatech Pharma PLC Announces R&D Programme Focused on Leptomeningeal Disease

  • Peyman Taeidi
  • March 27, 2023

ABINGDON, OXFORDSHIRE / ACCESSWIRE / March 27, 2023 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), a drug

  • More Science

Midatech Pharma PLC Announces R&D Programme Focused on Leptomeningeal Disease

  • Peyman Taeidi
  • March 27, 2023

ABINGDON, OXFORDSHIRE / ACCESSWIRE / March 27, 2023 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), a drug

  • More Science

Midatech Pharma PLC Announces R&D Programme Focused on Leptomeningeal Disease

  • Peyman Taeidi
  • March 27, 2023

ABINGDON, OXFORDSHIRE / ACCESSWIRE / March 27, 2023 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), a drug

  • More Science

Midatech Pharma PLC Announces R&D Programme Focused on Leptomeningeal Disease

  • Peyman Taeidi
  • March 27, 2023

ABINGDON, OXFORDSHIRE / ACCESSWIRE / March 27, 2023 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), a drug

Posts navigation

Prev 1 … 58 59 60 61 62 … 670 Next

Cream Magazine by Themebeez

  • Dr. Peyman Taeidi
  • Articles
  • News